| SCORTEN: a severity-of-illness score for toxic epidermal necrolysis N Fouchard, M Bertocchi, JC Roujeau, J Revuz, P Wolkenstein, ... Journal of Investigative Dermatology 115 (2), 149-153, 2000 | 1328 | 2000 |
| Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies JE Revuz, F Canoui-Poitrine, P Wolkenstein, C Viallette, G Gabison, ... Journal of the American Academy of Dermatology 59 (4), 596-601, 2008 | 743 | 2008 |
| Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis P Wolkenstein, J Latarjet, JC Roujeau, C Duguet, S Boudeau, L Vaillant, ... The Lancet 352 (9140), 1586-1589, 1998 | 509 | 1998 |
| Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells A Nassif, A Bensussan, L Boumsell, A Deniaud, H Moslehi, P Wolkenstein, ... Journal of allergy and clinical immunology 114 (5), 1209-1215, 2004 | 489 | 2004 |
| Quality of life impairment in hidradenitis suppurativa: a study of 61 cases P Wolkenstein, A Loundou, K Barrau, P Auquier, J Revuz, ... Journal of the American Academy of Dermatology 56 (4), 621-623, 2007 | 431 | 2007 |
| Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation E Legius, L Messiaen, P Wolkenstein, P Pancza, RA Avery, Y Berman, ... Genetics in Medicine 23 (8), 1506-1513, 2021 | 383 | 2021 |
| Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis C Paul, P Wolkenstein, H Adle, J Wechsler, HJ Garchon, J Revuz, ... British Journal of Dermatology 134 (4), 710-714, 1996 | 379 | 1996 |
| Severe cutaneous adverse reactions to drugs TA Duong, L Valeyrie-Allanore, P Wolkenstein, O Chosidow The Lancet 390 (10106), 1996-2011, 2017 | 366 | 2017 |
| Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity F Canoui-Poitrine, JE Revuz, P Wolkenstein, C Viallette, G Gabison, ... Journal of the American Academy of Dermatology 61 (1), 51-57, 2009 | 362 | 2009 |
| Patch testing in severe cutaneous adverse drug reactions, including Stevens‐Johnson syndrome and toxic epidermal necrolysis P Wolkenstein, O Chosidow, ML Fléchet, O Robbiola, M Paul, L Dume, ... Contact dermatitis 35 (4), 234-236, 1996 | 361 | 1996 |
| Association between benign and malignant peripheral nerve sheath tumors in NF1 T Tucker, P Wolkenstein, J Revuz, J Zeller, JM Friedman Neurology 65 (2), 205-211, 2005 | 336 | 2005 |
| Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study L Lantieri, JP Meningaud, P Grimbert, F Bellivier, JP Lefaucheur, ... The Lancet 372 (9639), 639-645, 2008 | 332 | 2008 |
| Elevated risk for MPNST in NF1 microdeletion patients T De Raedt, H Brems, P Wolkenstein, D Vidaud, S Pilotti, F Perrone, ... The American Journal of Human Genetics 72 (5), 1288-1292, 2003 | 330 | 2003 |
| Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients G Gener, F Canoui-Poitrine, JE Revuz, O Faye, F Poli, G Gabison, ... Dermatology 219 (2), 148-154, 2009 | 325 | 2009 |
| Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1) A retrospective study of 104 patients JS Guillamo, A Creange, C Kalifa, J Grill, D Rodriguez, F Doz, S Barbarot, ... Brain 126 (1), 152-160, 2002 | 325 | 2002 |
| Neurological complications of neurofibromatosis type 1 in adulthood A Creange, J Zeller, S Rostaing-Rigattieri, P Brugieres, JD Degos, ... Brain 122 (3), 473-481, 1999 | 307 | 1999 |
| Open trial of ciclosporin treatment for Stevens–Johnson syndrome and toxic epidermal necrolysis L Valeyrie‐Allanore, P Wolkenstein, L Brochard, N Ortonne, B Maître, ... British Journal of Dermatology 163 (4), 847-853, 2010 | 301 | 2010 |
| Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study F Canoui-Poitrine, A Le Thuaut, JE Revuz, C Viallette, G Gabison, F Poli, ... Journal of Investigative Dermatology 133 (6), 1506-1511, 2013 | 282 | 2013 |
| Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1 AE Lin, PH Birch, BR Korf, R Tenconi, M Niimura, M Poyhonen, ... American journal of medical genetics 95 (2), 108-117, 2000 | 281 | 2000 |
| Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study F Lebargy, P Wolkenstein, M Gisselbrecht, F Lange, J Fleury-Feith, ... Intensive care medicine 23, 1237-1244, 1997 | 271 | 1997 |
